financetom
Business
financetom
/
Business
/
Avista Q3 Earnings, Revenue Rise; Reaffirms 2025 Earnings Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avista Q3 Earnings, Revenue Rise; Reaffirms 2025 Earnings Guidance
Nov 5, 2025 3:37 AM

06:21 AM EST, 11/05/2025 (MT Newswires) -- Avista ( AVA ) reported Q3 earnings Wednesday of $0.36 per diluted share, up from $0.23 a year earlier.

Four analysts polled by FactSet expected $0.28.

Revenue for the quarter ended Sept. 30 for Avista Utilities was $394 million compared with $384 million a year earlier.

Two analysts surveyed by FactSet expected revenue of $417.8 million.

The company reaffirmed its 2025 consolidated earnings guidance of $2.52 to $2.72 per diluted share but expects results at the low end due to losses from other businesses. Analysts polled by FactSet expect $2.49.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints New reports
Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints New reports
Nov 4, 2025
Nov 4 (Reuters) - Eli Lilly ( LLY ) and Novo Nordisk are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs, in return for coverage of products under Medicare, Endpoints New reported on Tuesday, citing sources familiar with the matter. (Reporting by Sriparna Roy in Bengaluru) ...
Apollo Stock Gains After Earnings Beat
Apollo Stock Gains After Earnings Beat
Nov 4, 2025
Apollo Global Management, Inc. ( APO ) shares are trading higher Tuesday after the company reported better-than-expected adjusted earnings per share results. What To Know: Apollo reported adjusted earnings per share of $2.17, beating the consensus estimate of $1.91. In addition, the company reported sales of $9.82 billion, beating the consensus estimate of $5.02 billion. The company said fee-related earnings...
Update: Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger
Update: Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger
Nov 4, 2025
10:44 AM EST, 11/04/2025 (MT Newswires) -- (Updates with additional details starting in second paragraph.) Metsera ( MTSR ) said Tuesday its board received a superior amended acquisition proposal from Novo Nordisk ( NVO ) , challenging its existing merger agreement with Pfizer ( PFE ) . Novo Nordisk ( NVO ) would pay Metsera ( MTSR ) $62.20 per...
Ex-CFO of 'smart window' maker View must face SEC case, US judge rules
Ex-CFO of 'smart window' maker View must face SEC case, US judge rules
Nov 4, 2025
(Reuters) -The former chief financial officer of View must face U.S. Securities and Exchange Commission claims he negligently allowed the maker of smart windows to understate the cost of replacing defective windows, a federal judge ruled. In a Monday night decision, U.S. District Judge Beth Labson Freeman in San Jose, California, rejected ex-CFO Vidul Prakash's claim the SEC could not...
Copyright 2023-2026 - www.financetom.com All Rights Reserved